Literature DB >> 11823441

Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia.

Patrizia Cavadini1, Heather A O'Neill, Oldrich Benada, Grazia Isaya.   

Abstract

Friedreich ataxia (FRDA) is an autosomal recessive degenerative disease caused by a deficiency of frataxin, a conserved mitochondrial protein of unknown function. Mitochondrial iron accumulation, loss of iron-sulfur cluster-containing enzymes and increased oxidative damage occur in yeast and mouse frataxin-depleted mutants as well as tissues and cell lines from FRDA patients, suggesting that frataxin may be involved in export of iron from the mitochondria, synthesis of iron-sulfur clusters and/or protection from oxidative damage. We have previously shown that yeast frataxin has structural and functional features of an iron storage protein. In this study we have investigated the function of human frataxin in Escherichia coli and Saccharomyces cerevisiae. When expressed in E.coli, the mature form of human frataxin assembles into a stable homopolymer that can bind approximately 10 atoms of iron per molecule of frataxin. The iron-loaded homopolymer can be detected on non-denaturing gels by either protein or iron staining demonstrating a stable association between frataxin and iron. As analyzed by gel filtration and electron microscopy, the homopolymer consists of globular particles of approximately 1 MDa and ordered rod-shaped polymers of these particles that accumulate small electron-dense cores. When the human frataxin precursor is expressed in S.cerevisiae, the mitochondrially generated mature form is separated by gel filtration into monomer and a high molecular weight pool of >600 kDa. A high molecular weight pool of frataxin is also present in mouse heart indicating that frataxin can assemble under native conditions. In radiolabeled yeast cells, human frataxin is recovered by immunoprecipitation with approximately five atoms of (55)Fe bound per molecule. These findings suggest that FRDA results from decreased mitochondrial iron storage due to frataxin deficiency which may impair iron metabolism, promote oxidative damage and lead to progressive iron accumulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823441     DOI: 10.1093/hmg/11.3.217

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  72 in total

Review 1.  Neuronal degeneration and mitochondrial dysfunction.

Authors:  Eric A Schon; Giovanni Manfredi
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Yeast frataxin solution structure, iron binding, and ferrochelatase interaction.

Authors:  Yanan He; Steven L Alam; Simona V Proteasa; Yan Zhang; Emmanuel Lesuisse; Andrew Dancis; Timothy L Stemmler
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

3.  Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.

Authors:  Joseph P Sarsero; Timothy P Holloway; Lingli Li; Samuel McLenachan; Kerry J Fowler; Ivan Bertoncello; Lucille Voullaire; Sophie Gazeas; Panos A Ioannou
Journal:  Mamm Genome       Date:  2005-04       Impact factor: 2.957

4.  Structural, Mechanistic and Coordination Chemistry of Relevance to the Biosynthesis of Iron-Sulfur and Related Iron Cofactors.

Authors:  Wenbin Qi; J A Cowan
Journal:  Coord Chem Rev       Date:  2011-04-01       Impact factor: 22.315

Review 5.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

6.  An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1.

Authors:  Jana Gerber; Ulrich Mühlenhoff; Roland Lill
Journal:  EMBO Rep       Date:  2003-08-15       Impact factor: 8.807

7.  Identification of a novel candidate gene in the iron-sulfur pathway implicated in ataxia-susceptibility: human gene encoding HscB, a J-type co-chaperone.

Authors:  Guifeng Sun; J Jay Gargus; Dennis T Ta; Larry E Vickery
Journal:  J Hum Genet       Date:  2003-08-19       Impact factor: 3.172

8.  Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly.

Authors:  Filippo Prischi; Petr V Konarev; Clara Iannuzzi; Chiara Pastore; Salvatore Adinolfi; Stephen R Martin; Dmitri I Svergun; Annalisa Pastore
Journal:  Nat Commun       Date:  2010-10-19       Impact factor: 14.919

9.  Iron-sulfur (Fe/S) protein biogenesis: phylogenomic and genetic studies of A-type carriers.

Authors:  Daniel Vinella; Céline Brochier-Armanet; Laurent Loiseau; Emmanuel Talla; Frédéric Barras
Journal:  PLoS Genet       Date:  2009-05-29       Impact factor: 5.917

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.